Case Study.

Regulatory Affairs for accelerated EU software approval in the life sciences industry

A global software provider in the regulated life sciences sector needed an effective strategy to meet complex EU requirements. Without this strategy, there was a risk of significant delays and market access risks.

The Challenge.

New EU regulations required rapid adjustments for market access.

  • Lack of experience among subsidiaries increased the risk of delays
  • Unclear regulations caused uncertainty in the approval process
  • Long processing times threatened the planned product launch.

The Benefits.

  • Prioritization of critical regulatory issues to minimize delays
  • Alignment of the roadmap with regulatory requirements
  • Detailed analysis of change impacts for strategic decisions
  • Development of country-specific documentation to meet EU-specific requirements

The Outcome.

Accelerated CE approval

CE approval achieved in 50 countries through optimized, coordinated approval processes.

Successful software rollout

Global rollout enabled by strategic adaptation to local market requirements.

Reduced processing times

Processing times significantly reduced through targeted improvements to communication strategies.

The Result.

Faster time to market and improved scalability have resulted in a decisive competitive advantage in the European market.